Ghanaian scientist, Dr Owusu Bempah, resident in the UK, will present the results of his seven-year study on long-term, chronic diabetes complications at the 22nd International Congress on diabetes and complications to be held in London in October 12-13, 2017.

His presentation will cover the cause of long-term chronic diabetes complications such as, amputation, blindness, kidney and heart failure, stroke and erectile dysfunction; and the cure and prevention.

Diabetes complications are currently associated with high glucose concentration in the blood plasma (people with diabetes mellitus) and all efforts at finding cure and prevention have been unsuccessful.

Dr Bempah has proposed a new theory. He opines that diabetes complications are caused by polyuria – increased frequency in urination and volume of urine produced. According to him, polyuria initiates a concatenation of events that culminates in tissue damage that is described as diabetes complications.

Having elucidated the cause of the complications, he formulated a therapeutic tablet to be used daily by diabetes patients. The tablet, ingested one a day, has been used by diabetic patients over seven years to cure early-stage symptoms of diabetes complications. Regular continued use of the therapy has prevented new symptoms from developing.

Among the early-stage symptoms of the diabetes complications cured are: sores that resist healing, retinopathy (blurred vision), chronic swollen feet/ankles as indicator for kidney failure; burning feet sensations, gum sore and male erectile dysfunction.

Diagnosed with diabetes mellitus in 1988, he started developing early-stage symptoms of complications in 2000-2005. The former lecturer in chemistry at University of Cape Coast turned his attention to the study of diabetes and its complications. Dr Bempah says he was himself the guinea pig for his therapy and roped in his friends and acquaintances with diabetes complications. They reported back that their symptoms were all cured. He remains healthy and free from diabetes complications.

He has already published four papers in peer review medical journals on his research in the past two years.

He can be reached at kb436@outlook.com.